HCP+Patient Insights
Pharma knows more about what physicians prescribe than almost any industry knows about its audience - but far less about why. A look at how understanding the beliefs, identity, and cognitive patterns behind HCP decision-making unlocks better strategy than behavioral data alone ever can.
Read article
S+R News
Shapiro+Raj announces the expansion of Stella.ai as a direct offering for life sciences teams, with new leadership appointments to scale the platform's growth in pharma and biotech insights.
Read article
Pharma Branding
Clinical differentiation alone no longer guarantees market leadership. A look at why pharma is at the same brand-defining inflection point that reshuffled consumer packaged goods decades ago - and what companies must do now to build the trust, memory, and meaning that turns a strong molecule into a durable brand.
Read article
PHARMA BRANDING
The Customer Has Changed. Pharma’s Commercial Model Hasn’t.
Pharma modernized its sales force, channels, and analytics but kept one assumption: the physician is the customer. Zain Raj argues the real customer is now a decision system of payers, pathways, health systems, and patients, and that commercial advantage depends on mapping where power lives.
Sep 22, 2026
READ MORE →
HCP+PATIENT INSIGHTS
Better Science Doesn’t Sell Itself
Physicians don't adopt better treatments just because the evidence says they should. Explore why superior clinical data alone fails to change prescribing behavior — and what actually moves it: understanding the friction, habit, and structural barriers standing in the way.
Sep 19, 2026
READ MORE →
PHARMA BRANDING
Everyone Launches. Almost No One Lands.
Most pharma launches fail on positioning, not science. Competitive data shows where every player stands, but finding defensible ground takes judgment, not analysis. Zain Raj argues speed and insight, not more data, are what separate launches that land from launches that merely happen.
Sep 12, 2026
READ MORE →
HCP+PATIENT INSIGHTS
Could We Have Predicted the Study Before We Ran It?
A global oncology client asked Stella to predict how physicians would react to a new asset before running primary market research. Here's where her predictions held, where they broke down, and what it means for how much PMR you still need.
Aug 25, 2026
READ MORE →
HCP+PATIENT INSIGHTS
Physicians Are People First. Prescribers Second.
Pharma knows more about what physicians prescribe than almost any industry knows about its audience - but far less about why. A look at how understanding the beliefs, identity, and cognitive patterns behind HCP decision-making unlocks better strategy than behavioral data alone ever can.
Apr 28, 2026
READ MORE →
S+R NEWS
Shapiro+Raj Launches an AI Agent Built Specifically for the Life Sciences Industry
Shapiro+Raj announces the expansion of Stella.ai as a direct offering for life sciences teams, with new leadership appointments to scale the platform's growth in pharma and biotech insights.
Apr 22, 2026
READ MORE →Subscribe to receive the latest thinking on life sciences, strategy, and innovation.
Let's discuss how we can accelerate your strategic decisions.